References
- Yoshimasu T, Ohtani T, Sakamoto T et al, Topical FK506 (tacrolimus) therapy for skin lesions of cutaneous lupus erythematodes and dermatomyositis. Eur J Dermatol (2002) 12: 50–52.
- Furukawa F, Yoshimasu T, Ohtani T et al, Topical tacrolimus therapy for lesions of cutaneous lupus erythematosus: reply to the comments of Drs. Walker, Kirby and Chalmers. Eur J Dermatol (2002) 12: 389 (letter).
- Walker SL, Kirby B, Chalmers RJG, The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Eur J Dermatol (2002) 12: 387-8 (letter).
- Kanekura T, Yoshii N, Terasaki K et al, Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus. Br J Dermatol (2003) 148: 353–6.
- Peters DH, Fitton A, Plosker GL, Faulds D, Tacrolimus: a review of its pharmacology and therapeutic potential in hepatic and renal transplantation. Drugs (1993) 46: 746–94.
- Heilig B, Fiehn C, Brockhaus M et al, Evaluation of soluble tumour necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J Clin Immunol (1993) 13: 321–8.
- Stein LF, Saed GM, Fivenson DP, T-cell cytokine network in cutaneous lupus erythematosus. J Am Acad Dermatol (1997) 36: 191–6.
- Griffiths B, Emery P, The treatment of lupus with cyclosporin A. Lupus (2001) 10: 165–70.
- Duddridge M, Powell RJ, Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus: a report of three cases. Ann Rheum Dis (1997) 56: 690–93.